Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
25 nov. 2020 12h00 HE
|
Teligent, Inc.
Scheduled to Reconvene on December 16, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
11 nov. 2020 10h54 HE
|
Teligent, Inc.
Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
22 oct. 2020 11h25 HE
|
Teligent, Inc.
Scheduled to Reconvene on November 11, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
Teligent Announces Completion of Series D Convertible Note Exchange
23 sept. 2020 08h50 HE
|
Teligent, Inc.
BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
Teligent, Inc. Announces Second Quarter 2020 Results
19 août 2020 07h30 HE
|
Teligent, Inc.
BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second...
Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020
14 août 2020 08h30 HE
|
Teligent, Inc.
BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
Teligent Announces Completion of Series C Convertible Note Financing and Exchange
20 juil. 2020 16h05 HE
|
Teligent, Inc.
BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board
20 juil. 2020 08h45 HE
|
Teligent, Inc.
BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that...
Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary
17 juil. 2020 08h45 HE
|
Teligent, Inc.
BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of...
Teligent Regains Compliance with NASDAQ Listing Requirements
22 juin 2020 16h15 HE
|
Teligent, Inc.
BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it...